American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Bausch Health Companies Inc.

$5.11 -4.84% NYSE: BHC · 15-min delayed

QUEBEC,
Public · NYSE: BHC
20,300 employees

Visit website Follow

$2.0BMarket cap

$10.3BRevenue · FY2025

$157.0MNet income

20,300Employees

BHCNYSE

1994IPO

About Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NYSE: BHC
Employees: 20,300
IPO date: Mar 31, 1994
Headquarters: 2150 ST. ELZEAR BLVD. WEST
QUEBEC, H7L 4A8
Phone: 514-744-6792
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: BHC NYSE
SEC CIK: 885590
LEI: B3BS7ACMDUWISF18KY76
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Bausch Health Companies Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $10.3B
Net income: $157.0M
Total assets: $26.4B
Market cap: $2.0B
Operating margin: 17.7%
Net margin: 1.2%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2021

FY2022

FY2023

FY2024

FY2025

Revenue Net income

FY 2025

Financial statements

Income statement

Revenue: $10.3B
Operating expenses: $8.5B
Operating income: $1.8B
Income tax: $247.0M
Net income: $120.0M
EPS (basic): $0.42
EPS (diluted): $0.42

Balance sheet

Total assets: $26.4B
Current assets: $6.2B
Total liabilities: $26.0B
Current liabilities: $4.2B
Shareholders’ equity: $377.0M

Cash flow

Operating cash flow: $1.4B
Investing cash flow: -$595.0M
Financing cash flow: -$742.0M
Net cash flow: $124.0M

Statements via Polygon.io (SEC filings)

NYSE: BHC

$5.11 -4.84%

15-minute delayed · data by Polygon.io

Past year

$4.45 $8.34

52-week range

Market cap: $2.0B
P/E ratio: 12.2
EPS (diluted): $0.42
Shares outstanding: 392.5M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Mar 31, 1994

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

Profitable — net income of $157.0M in FY2025.
Revenue grew 22% from FY2021 to FY2025.
Trading 39% below its 52-week high.
Valued at a price-to-earnings (P/E) ratio of 12.2.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Bausch Health Companies Inc..

Write a review